Download Poster (262.56 KB)

Publication

ISTH •
24 June, 2025 •
•

Long-term observational joint health study in patients initiating efanesoctocog alfa: baseline data

Jonathan C. Roberts, Larissa Bornikova, Eric Grabowski, Amit Soni, Jennifer Dumont, Charlotte Sensinger, Nicole Tsao

Available materials

Poster

Publication

ISTH •
24 June, 2025 •
•

Major Surgical Outcomes with Efanesoctocog Alfa: 4 Years’ Experience in the XTEND Clinical Program

Liane Khoo, Robert Klamroth, Annette von Drygalski, Sandrine Meunier, Davide Matino, Umer Khan, Elena Santagostino, Lara Mamikonian, Linda Bystrická, Graham Neill, Flora Peyvandi

Available materials

Oral Presentation

Publication

ISTH •
24 June, 2025 •
•

Analysis of Baseline Influences on Platelet Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Pati

Rachael F. Grace, Göksel Leblebisatan, Yesim Aydinok, Şule Ünal, John Grainger, Amanda Grimes, Michele Lambert, Jessica Zhang, Brian D. Jamieson, Michael Vredenburg , Scott Kolodny

Available materials

Poster

Publication

Monitoring Joint Health in Hemophilia Patients in Spain: Updated Analysis of the JOINt US Project

Long-term observational joint health study in patients initiating efanesoctocog alfa: baseline data

Major Surgical Outcomes with Efanesoctocog Alfa: 4 Years’ Experience in the XTEND Clinical Program

Analysis of Baseline Influences on Platelet Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Pati

Using the Hemophilia Functional Ability Scoring Tool (Hemo-FAST) to describe the joint health status in adults with hemophilia